Raleigh Capital Management Inc. Pfizer Inc Transaction History

Raleigh Capital Management Inc.

$261 Million
Q4 2025

A detailed history of Raleigh Capital Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 101,373 shares of PFE stock, worth $2.54 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

101,373

Previous 94,043 7.79%

Holding current value

$2.54 Million

Previous $2.4 Million 6.09%

% of portfolio

0.97%

Previous 0.97%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 21, 2026	BUY	$24.23 - $27.37 $177,605 - $200,622	7,330 Added 7.79%	101,373 $2.54 Million
Q3 2025 Nov 04, 2025	BUY	$23.29 - $25.88 $377,554 - $419,540	16,211 Added 20.83%	94,043 $2.4 Million
Q2 2025 Jul 17, 2025	BUY	$21.59 - $24.84 $320,050 - $368,228	14,824 Added 23.53%	77,832 $1.89 Million
Q1 2025 Apr 29, 2025	BUY	$25.01 - $27.13 $122,073 - $132,421	4,881 Added 8.4%	63,008 $1.6 Million
Q4 2024 Jan 17, 2025	SELL	$24.8 - $30.19 $54,684 - $66,568	-2,205 Reduced 3.65%	58,127 $1.54 Million

Q3 2024 Oct 21, 2024	SELL	$27.7 - $31.39 $41,439 - $46,959	-1,496 Reduced 2.42%	60,332 $1.75 Million
Q2 2024 Jul 31, 2024	SELL	$25.26 - $29.6 $225,521 - $264,268	-8,928 Reduced 12.62%	61,828 $1.73 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $162,459 - $186,555	6,275 Added 9.73%	70,756 $1.96 Million
Q4 2023 Feb 21, 2024	SELL	$26.13 - $33.94 $59,315 - $77,043	-2,270 Reduced 3.4%	64,481 $1.86 Million
Q3 2023 Dec 07, 2023	BUY	$32.09 - $37.51 $26,859 - $31,395	837 Added 1.27%	66,751 $2.21 Million
Q3 2023 Dec 06, 2023	BUY	$32.09 - $37.51 $20,762 - $24,268	647 Added 0.99%	65,914 $2.19 Million
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $105,723 - $122,319	2,927 Added 4.7%	65,267 $2.39 Million
Q1 2023 May 22, 2023	BUY	$39.39 - $51.28 $464,802 - $605,104	11,800 Added 23.35%	62,340 $2.54 Million
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $356,503 - $465,375	8,539 Added 20.33%	50,540 $2.59 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $298,880 - $364,858	6,830 Added 19.42%	42,001 $1.84 Million
Q2 2022 Aug 30, 2022	BUY	$46.53 - $55.17 $151,315 - $179,412	3,252 Added 10.19%	35,171 $1.84 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $1.44 Million - $1.79 Million	31,537 Added 8255.76%	31,919 $1.65 Million
Q4 2021 Feb 16, 2022	BUY	$41.32 - $61.25 $15,784 - $23,397	382 New	382 $23,000

Others Institutions Holding PFE

# of Institutions

3,382

Shares Held

3.57B

Call Options Held

86.7M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.

Account

Raleigh Capital Management Inc. Pfizer Inc Transaction History